MORRISTOWN, N.J. Generic drug maker Actavis has reintroduced oxycodone tablets following an injunction last year by the Food and Drug Administration. The company announced last week that its ...

Actavis' sales of the generic version of OxyContin and other drugs containing oxycodone grew from 559 million in 2006 to more than 1.1 billion in 2012, according to the DEA database.

Cargo thieves have struck again, stealing more than 30 pallets of opioid analgesics, benzodiazepines and epilepsy drugs made by the generics firm Actavis. The missing meds include 14 pallets of ...

Actavis’s sales of the generic version of OxyContin and other drugs containing oxycodone grew from 559 million in 2006 to more than 1.1 billion in 2012, according to the DEA database.

The fully loaded tractor-trailer was traveling from an Actavis site in Elizabeth, NJ, to a warehouse in ... 14 held oxycodone HCl tablets, 6 carried anxiety drug alprazolam and 9 contained the ...

Opioid (oxycodone and hydrocodone) ... Main distributors: 67,416,610 of the pills were distributed by Walgreen Co. and 68,001,190 were manufactured by Actavis Pharma, Inc., ...

Unlike the criminal case, however, Floyd’s lawsuit names oxycodone manufacturer Actavis Pharma and New York-based pharmacy Duane Reade as defendants. “We think that this litigation is going to get ...

A county-level analysis shows where the most oxycodone and hydrocodone pills were distributed across the country over that time — more than 145 billion in all.

MoxDuo IR is a patented 3:2 ratio fixed dose combination of morphine and oxycodone. Actavis Inc. is a subsidiary of Actavis Group, hf a privately held company based in Europe with 10,000 employees ...

A U.S. appeals court on Thursday upheld three Tris Pharma Inc patents covering a form of its ADHD drug Quillivant, rejecting a challenge from Teva Pharmaceuticals-owned generic drugmaker Actavis ...

Actavis' sales of the generic version of OxyContin and other drugs containing oxycodone grew from 559 million in 2006 to more than 1.1 billion in 2012, according to the DEA database.

Actavis’ sales of the generic version of OxyContin and other drugs containing oxycodone grew from 559 million in 2006 to more than 1.1 billion in 2012, according to the DEA database.